Background
Prior studies suggest that disease activity alone does not reliably predict hospital readmission among patients with inflammatory bowel diseases (IBD). Using a national database, we aimed to further describe the burden of readmissions for IBD and identify modifiable risk factors.
Methods
We performed a retrospective cohort study using 2013 data from the Nationwide Readmission Database (NRD). Using International Classification of Diseases-9th Revision, Clinical Modification (ICD-9-CM) codes, we identified adult patients with discharge diagnoses of ulcerative colitis (UC) or Crohn's disease (CD) and ascertained diagnoses of anxiety, depression, chronic pain, tobacco use, and other comorbidites during index admission. Logistic regression was used to estimate factors associated with hospital readmission.
Results
Among 52,498 hospitalizations of IBD patients (63% CD and 37% UC), 12,407 (24%) were readmitted within 90 days of the index hospitalization resulting in roughly $576 million in excess charges. In multivariable analysis of patients with CD, anxiety (OR 1.31, 95%CI:1.21–1.43), depression (OR 1.27, 95%CI:1.07–1.50), chronic pain (OR 1.31, 95%CI:1.18–1.46), and tobacco abuse (OR 1.13, 95%CI:1.06–1.22) were associated with a significant increase in odds of readmission. Among patients with UC, anxiety (OR 1.28, 95%CI:1.14–1.45), depression (OR 1.35, 95%CI:1.07–1.70), and chronic pain (OR 1.44, 95%CI:1.21–1.73) were associated with a significant increase in odds of readmission.
Conclusions
Readmission occurs frequently in patients with IBD, and is costly. Anxiety, depression, and chronic pain may represent targets for interventions to prevent 90 day hospital readmission in this population.